Top 5 Best-Selling Cancer Drugs

Page 1 of 5

In this article, we will be taking a look at the Top 5 Best-Selling Cancer Drugs. If you wish to learn about the cancer treatment market, head straight to the Top 15 Best-Selling Cancer Drugs.

5. Darzalex 

Total Sales: 13.9 billion  

Darzalex (daratumumab) is a monoclonal antibody for multiple myeloma, demonstrating substantial commercial success. In 2023, its net sales reached USD 5,277 million in the U.S. and USD 4,467 million globally, reflecting a robust growth trajectory. Genmab’s financial performance saw net sales of USD 7,194 million in the first nine months of 2023, a notable increase from the same period in 2022. With a 38.7% growth worldwide, Darzalex is a pharmaceutical standout, actively contributing to treating multiple myeloma.

Page 1 of 5